In the immune-high subtype, we identified four patients positive for PD-L1 (Figure 9A), defined as >1% of positive cancer cells, as previously reported [38], while the immune-low subtype showed only two patients positive for PD-L1 (Figure 9B). This evidence concerns the gene CD274 and cancer.